Overview of the Requirements on WFI in the EU, USA and Japan
![Granulation & Tableting - Live Online Training](files/eca/userImages/training.img/Z-ECA-Granulation-Tableting-2024-Live-Online.jpg)
Recommendation
17-19 September 2024
GMP Compliance and Technology for the Manufacture of Oral Solid Dosage Forms
Again and again, the question arises about the limits laid down in the different GMP regulations and Pharmacopoeias and what procedures are applicable to the manufacture of water for injection (WFI). The table below gives you an overview of the current requirements on the production as well as on certain testing elements. It is remarkable to notice that only EU authorities are against the inclusion of membrane procedures for the production of WFI.
| USP | EP | JP |
Production of WFI | Distillation or purification process proven to be equivalent or superior to distillation | Distillation only | Distillation or RO/UF |
Conductivity [µS/cm at 25 °C or equivalent at other temperatures] | 1.3 | 1.3 | 1.3 |
TOC [ppb] | ≤ 500 | ≤500 | ≤ 500 |
Endotoxin | 0.25 EU/mL | 0.25 EU/mL | 0.25 EU/mL |
Bacteria [cfu/100 mL] | 10 | 10 | 10 |
Nitrates [ppm] | N/A | 0.2 | N/A |
Ammonium [mg/L] | N/A | N/A | N/A |
Related GMP News
24.07.2024EDQM publishes updated Ph.Eur. Water Monographs for comment
10.07.2024The EU GMP Annex 1 (2022) and the 5 µm Particles in Grade A & B
03.07.2024FDA publishes Final Rule on Medical Gases
26.06.2024Testing of Medicinal Products is no Evidence against Cross-Contamination
19.06.2024Warning Letter to Indian Sterile Manufacturer due to egregious GMP Deficiencies
12.06.2024Requalification of an Automatic Inspection System (AVI)